FDI Clinical Research | San Juan, PR
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of Care (SOC) has failed or has proven intolerable.
Full description
The main questions this clinical trial aims to answer are:
Participants will be asked to:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
48 participants in 1 patient group
Loading...
Central trial contact
Jose Rodriguez-Orengo, PhD; Scott Houston
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal